0000000000905537

AUTHOR

Carmen Vidal-real

showing 1 related works from this author

Osteonecrosis of the jaws in 194 patients who have undergone intravenous bisphosphonate therapy in Spain.

2014

Background: Osteonecrosis of the jaw (ONJ) is a destructive bone process in patients undergoing bisphosphonate therapy and it is modulated by local and systemic factors. The purpose of this article is to determine the prevalence of ONJ in patients who have undergone intravenous bisphosphonate therapy, and relate the risk factors described to establish a protocol to reduce the risk of developing ONJ. Material and Methods: We performed a retrospective study on 194 patients treated with IV bisphosponates, analyzing clinical and pathological variables. Results: The prevalence of ONJ was 12.9 %. The most remarkable complication was pain, which was reported by 80% of patients. The average age of …

AdultMalemedicine.medical_specialtyOdontologíaOral hygieneRisk FactorsmedicinePrevalenceHumansRisk factorGeneral DentistryPathologicalAgedRetrospective StudiesAged 80 and overBisphosphonate-associated osteonecrosis of the jawOral Medicine and PathologyBone Density Conservation AgentsDiphosphonatesbusiness.industryResearchRetrospective cohort studyMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryOtorhinolaryngologySpainUNESCO::CIENCIAS MÉDICASEtiologySurgeryBisphosphonate-Associated Osteonecrosis of the JawFemaleOsteonecrosis of the jawComplicationbusinessMedicina oral, patologia oral y cirugia bucal
researchProduct